Biotechnology · Healthcare
Chairman
2025-05-09–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Canton Strategic Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get CNTN alertsVincent LoPriore is recorded as Chairman at Canton Strategic Holdings, Inc. (CNTN) since May 9, 2025. Canton Strategic Holdings, Inc. reported in an 8-K filed June 11, 2025 that Vincent LoPriore was appointed Executive Chairman of the Board, effective May 9, 2025. Canton Strategic Holdings, Inc. reported in an 8-K filed May 9, 2025 that Vincent LoPriore was appointed Executive Chairman of the Board, effective May 9, 2025. Canton Strategic Holdings, Inc. reported in an 8-K filed April 10, 2025 that Vincent LoPriore was appointed member of the Board, effective April 9, 2025. Canton Strategic Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Canton Strategic Holdings, Inc. includes Mark Wendland (CEO, Chairman and Board Member), Sireesh Appajosyula (CEO and CFO), Don Kim (CFO) and 7 others.
“the Board of the Company appointed Vincent LoPriore, a director of the Company, as Executive Chairman of the Board, May 9, 2025.”
“On May 9, 2025, the Board of Directors (the “Board”) of Tharimmune, Inc. (the “Company”) appointed Vincent LoPriore, a director of the Company, as Executive Chairman of the Board, effective immediately.”
2025-05-09–present
Start not stated–2025-04-30
Last confirmed by a filing; no departure on record
Biotechnology · Healthcare
Chairman
2025-05-09–present